Hemostats Market Research Report Information By Product Type (Thrombin Based, Collagen Based, Tissue Sealants-Fibrin Sealants, and Others), By Instrument Type (Halstead Mosquito Hemostatic Forceps), By Application (Gynecology, Neurology, and Cardiovascular), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Hemostats Market, by Product Type

6.1 Introduction

6.2 Thrombin based

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

6.3 Combination based

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

6.4 Oxidized regenerated cellulose based

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

6.5 Gelatin based

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

6.6 Collagen-based

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

6.7 Tissue sealant

6.7.1 Fibrin sealants

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

6.7.2 Protein-based sealants

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

6.8 Cyanoacrylate-based tissue adhesives

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

6.9 Adhesion prevention products

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

Chapter 7. Global Hemostats Market, by Instrument Type

7.1 Introduction

7.2 Halstead mosquito hemostatic forceps

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

7.3 Kelly and Crile hemostatic forceps

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

7.4 Rochester-carmalt hemostatic forceps

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

Chapter 8. Global Hemostats Market, by Application

8.1 Introduction

8.2 Cardiovascular surgery

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

8.3 General surgery

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

8.4 Gynecological surgery

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

8.5 Reconstructive surgery

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

8.6 Neurological surgery

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

8.7 Orthopedic surgeries

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

8.8 Other surgeries

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

Chapter 9. Global Hemostats Market, by End-Users

9.1 Introduction

9.2 Hospitals

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

9.3 Clinics

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

9.4 Ambulatory Surgery Centers

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

9.5 Community healthcare

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

9.6 Others

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

Chapter 10. Global Hemostats Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 South Korea

10.4.6 Rest of Asia-Pacific

10.5 Middle East & Africa

10.5.1 Middle East

10.5.2 Africa

Chapter 11. Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

Chapter 12. Company Profiles

12.1 CR Bard, Inc.

12.1.1 Company Overview

12.1.2 Product Type Overview

12.1.3 Financials Overview

12.1.4 Key Developments

12.1.5 SWOT Analysis

12.2 B. Braun Melsungen AG

12.2.1 Company Overview

12.2.2 Product Type Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Baxter International, Inc.

12.3.1 Company Overview

12.3.2 Product Type Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Integra LifeSciences

12.4.1 Company Overview

12.4.2 Technology/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Marine Polymer Technologies, Inc.

12.5.1 Company Overview

12.5.2 Product Type Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.6 Teleflex

12.6.1 Company Overview

12.6.2 Product Type Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.7 Ethicon, Inc.

12.7.1 Overview

12.7.2 Product Type Overview

12.7.3 Financial Overview

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Pfizer, Inc.

12.8.1 Overview

12.8.2 Product Type/ Technology Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 Z-Medica LLC

12.9.1 Overview

12.9.2 Product Type Overview

12.9.3 Financials

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.10 Gelita Medical GmbH

12.10.1 Overview

12.10.2 Product Type Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.12 Anika Therapeutics, Inc.

12.12.1 Overview

12.12.2 Product Type Overview

12.12.3 Financials

12.12.4 Key Developments

12.12.5 SWOT Analysis

12.12 Stryker

12.12.1 Overview

12.12.2 Product Type Overview

12.12.3 Financials

12.12.4 Key Developments

12.12.5 SWOT Analysis

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s Viewpoint

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Predictions for the Global Hemostats Market Industry

Chapter 14. Appendix

LIST OF TABLES

Table 1 Global Hemostats Market Synopsis, 2023-2030

Table 2 Global Hemostats Market Estimates and Forecast, 2023-2030 (USD Million)

Table 3 Global Hemostats Market, by Region, 2023-2030 (USD Million)

Table 4 Global Hemostats Market, by Product Type, 2023-2030 (USD Million)

Table 5 Global Hemostats Market, by Instrument Type, 2023-2030 (USD Million)

Table 6 Global Hemostats Market, by Application, 2023-2030 (USD Million)

Table 7 Global Hemostats Market, by End-users, 2023-2030 (USD Million)

Table 8 North America: Global Hemostats Market, by Product Type, 2023-2030 (USD

Million)

Table 9 North America: Global Hemostats Market, by Instrument Type, 2023-2030 (USD

Million)

Table 10 North America: Global Hemostats Market, by Application, 2023-2030 (USD

Million)

Table 11 North America: Global Hemostats Market, by End-users, 2023-2030 (USD Million)

Table 12 US: Global Hemostats Market, by Product Type, 2023-2030 (USD Million)

Table 13 US: Global Hemostats Market, by Instrument Type, 2023-2030 (USD Million)

Table 14 US: Global Hemostats Market, by Application, 2023-2030 (USD Million)

Table 15 US: Global Hemostats Market, by End-users, 2023-2030 (USD Million)

Table 16 Canada: Global Hemostats Market, by Product Type, 2023-2030 (USD Million)

Table 17 Canada: Global Hemostats Market, by Instrument Type, 2023-2030 (USD Million)

Table 18 Canada: Global Hemostats Market, by Application, 2023-2030 (USD

Million)

Table 19 Canada Global Hemostats Market, by End-users, 2023-2030 (USD Million)

Table 20 South America: Global Hemostats Market, by Product Type, 2023-2030 (USD

Million)

Table 21 South America: Global Hemostats Market, by Instrument Type, 2023-2030 (USD

Million)

Table 22 South America: Global Hemostats Market, by Application, 2023-2030 (USD

Million)

Table 23 South America: Global Hemostats Market, by End-users, 2023-2030 (USD Million)

Table 24 Europe: Global Hemostats Market, by Product Type, 2023-2030 (USD Million)

Table 25 Europe: Global Hemostats Market, by Instrument Type, 2023-2030 (USD Million)

Table 26 Europe: Global Hemostats Market, by Application, 2023-2030 (USD Million)

Table 27 Europe: Global Hemostats Market, by End-users, 2023-2030 (USD Million)

Table 28 Western Europe: Global Hemostats Market, by Product Type, 2023-2030 (USD

Million)

Table 29 Western Europe: Global Hemostats Market, by Instrument Type, 2023-2030 (USD

Million)

Table 30 Western Europe: Global Hemostats Market, by Application, 2023-2030

(USD Million)

Table 31 Western Europe: Global Hemostats Market, by End-users, 2023-2030 (USD Million)

Table 32 Eastern Europe: Global Hemostats Market, by Product Type, 2023-2030 (USD

Million)

Table 33 Eastern Europe: Global Hemostats Market, by Instrument Type, 2023-2030 (USD

Million)

Table 34 Eastern Europe: Global Hemostats Market, by Application, 2023-2030

(USD Million)

Table 35 Eastern Europe: Global Hemostats Market, by End-users, 2023-2030 (USD Million)

Table 36 Asia-Pacific: Global Hemostats Market, by Product Type, 2023-2030 (USD

Million)

Table 37 Asia-Pacific: Global Hemostats Market, by Instrument Type, 2023-2030 (USD

Million)

Table 38 Asia-Pacific: Global Hemostats Market, by Application, 2023-2030 (USD

Million)

Table 39 Asia-Pacific: Global Hemostats Market, by End-users, 2023-2030 (USD Million)

Table 40 Middle East & Africa: Global Hemostats Market, by Product Type, 2023-2030

(USD Million)

Table 41 Middle East & Africa: Global Hemostats Market, by Instrument Type, 2023-2030

(USD Million)

Table 42 Middle East & Africa: Global Hemostats Market, by Application, 2023-2030

(USD Million)

Table 43 Middle East & Africa: Global Hemostats Market, by End-users, 2023-2030 (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Hemostats Market

Figure 3 Segmentation Market Dynamics for Global Hemostats Market

Figure 4 Global Hemostats Market Share, by Product Type, 2023

Figure 5 Global Hemostats Market Share, by Instrument Type, 2023

Figure 6 Global Hemostats Market Share, by Application, 2023

Figure 7 Global Absorbable Surgical Sutures, by End-users, 2023-2030 (USD Million)

Figure 8 Global Hemostats Market Share, by Region, 2023

Figure 9 North America: Global Hemostats Market Share, by Country, 2023

Figure 10 Europe: Global Hemostats Market Share, by Country, 2023

Figure 11 Asia-Pacific: Global Hemostats Market Share, by Country, 2023

Figure 12 Middle East & Africa: Global Hemostats Market Share, by Country, 2023

Figure 13 Global Hemostats Market: Company Share Analysis, 2023 (%)

Figure 14 CR Bard, Inc.: Key Financials

Figure 15 CR Bard, Inc.: Segmental Revenue

Figure 16 CR Bard, Inc.: Geographical Revenue

Figure 17 B. Braun Melsungen AG: Key Financials

Figure 18 B. Braun Melsungen: Segmental Revenue

Figure 19 B. Braun Melsungen: Geographical Revenue

Figure 20 Baxter International, Inc.: Key Financials

Figure 21 Baxter International, Inc.: Segmental Revenue

Figure 22 Baxter International, Inc.: Geographical Revenue

Figure 23 Integra LifeSciences: Key Financials

Figure 24 Integra LifeSciences: Segmental Revenue

Figure 25 Integra LifeSciences: Geographical Revenue

Figure 26 Marine Polymer Technologies, Inc.: Key Financials

Figure 27 Marine Polymer Technologies, Inc.: Segmental Revenue

Figure 28 Marine Polymer Technologies, Inc.: Geographical Revenue

Figure 29 Teleflex: Key Financials

Figure 30 Teleflex: Segmental Revenue

Figure 31 Teleflex: Geographical Revenue

Figure 32 Ethicon, Inc.: Key Financials

Figure 33 Ethicon, Inc.: Segmental Revenue

Figure 34 Ethicon, Inc.: Geographical Revenue

Figure 35 Pfizer, Inc.: Key Financials

Figure 36 Pfizer, Inc.: Segmental Revenue

Figure 37 Pfizer, Inc.: Geographical Revenue

Figure 38 Z-Medica LLC: Key Financials

Figure 39 Z-Medica LLC: Segmental Revenue

Figure 40 Z-Medica LLC: Geographical Revenue

Figure 41 Gelita Medical GmbH: Key Financials

Figure 42 Gelita Medical GmbH: Segmental Revenue

Figure 43 Gelita Medical GmbH: Geographical Revenue

Figure 44 Anika Therapeutics, Inc.: Key Financials

Figure 45 Anika Therapeutics, Inc.: Segmental Revenue

Figure 46 Anika Therapeutics, Inc.: Geographical Revenue

Figure 47 Stryker: Key Financials

Figure 48 Stryker: Segmental Revenue

Figure 49 Stryker: Geographical Revenue